chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swollen/stiff/sore finger joints; swollen/stiff/sore finger joints; swollen/stiff/sore finger joints; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 18Mar2021 at 16:30 (at the age of 42-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included asthma. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included sertraline hydrochloride (ZOLOFT), loratadine (CLARITIN), and vitamin B12 from unknown dates for unknown indications. The patient did not have any allergies to medications, food, or other products. On an unspecified date after dose 1 of BNT162B2, the patient experienced swollen, stiff, sore finger joints that had not fully recovered. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of swollen, stiff, and sore finger joints that had not fully recovered were recovering. The patient received dose 2 of BNT162B2 on 08Apr2021 at 16:00. It was also reported that since the vaccine, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Patient tested positive for Covid) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Sep-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Patient tested positive for Covid). At the time of the report, SARS-COV-2 TEST POSITIVE (Patient tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Sep-2021, SARS-CoV-2 test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were mild medicines.  Batch numbers of two doses are not provided.  None treatment medications were reported.; Sender's Comments: This case concerns an elderly 72-year-old male patient with no relevant medical history provide, who was tested positive for COVID-19 (the unexpected event of SARS-CoV-2 test positive). The event occurred approximately 6 and a half months months after the second dose of Moderna COVID-19 Vaccine. There were no reported signs of symptoms of COVID-19 disease, and there was no information that the COVID-19 diagnosis was established. Based on biological implausibility and having in mind that the mRNA-1273 does not contain a virus capable of causing infection, the Company causality for the reported event is not applicable. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
12/09/21 presents to EC ED for "chest pain with taking a deep breath, shortness of breath". PMHx of "htn, HLD, obesity"
Approximately 5 minutes after administration of the vaccine, the patient mentioned to her husband that she did not feel well. She then became unconscious and stopped breathing. Immediately after, 0.3 mg of epinephrine was administered to the right thigh. The patient did not respond to this dose, so another 0.3 mg was administered. The patient then began to breathe and responding to my voice. The patient was then able to speak and sit up shortly after. EMS arrived, took vitals, and took her to the nearest hospital.
COVID-19 pneumonia; Weakness; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of COVID-19 PNEUMONIA (COVID-19 pneumonia) and ASTHENIA (Weakness) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Artificial cardiac pacemaker user and COVID-19 on 01-Feb-2021. Concurrent medical conditions included Chronic kidney disease (20 years).   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced COVID-19 PNEUMONIA (COVID-19 pneumonia) (seriousness criteria hospitalization prolonged and medically significant) and ASTHENIA (Weakness) (seriousness criterion hospitalization prolonged). The patient was hospitalized from 05-Feb-2021 to 15-Feb-2021 due to ASTHENIA and COVID-19 PNEUMONIA. At the time of the report, COVID-19 PNEUMONIA (COVID-19 pneumonia) and ASTHENIA (Weakness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, COVID-19: positive (Positive) positive. On 01-Feb-2021, Oxygen consumption: low (Low) low.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment information provided mentioned that patient was prescribed vitamin C, vitamin D zinc and steroid. The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Healthcare professional was consulted on 05 Feb 2021.   Patient was admitted on 05 Feb 2021 and discharged on 15 Feb2021.  Patient received Nursing House rehab which included oxygen, steps and walking.  Based on the current available information and temporal association between the use of the product and the start date of these event (asthenia), a causal relationship cannot be excluded. Based on the mechanism of action of mRNA-1273, the event (Covid-19 pneumonia) is assessed as unlikely related to mRNA-1273. Further information has been requested.   This case was linked to MOD-2021-037770 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these event (asthenia), a causal relationship cannot be excluded. Based on the mechanism of action of mRNA-1273, the event (Covid-19 pneumonia) is assessed as unlikely related to mRNA-1273. Further information has been requested. MOD-2021-037770:Same patient 2nd dose for the case MOD-2021-037770
2/19/2021- PCP visit for 1-week history of constipation, malaise and bilateral leg weakness .  Abnormal sCr and LFTs AKI: likely ATN from rhabdomyolysis. Requiring HD 2/23/2021 initial hemodialysis  2/23/2021 kidney biopsy  3/1/2021 second hemodialysis
Within 7-10 min following Td & MMR immun to pt complained of tighting in the throat/shortness of breath, difficulity in swollowing & horseness. Rxd: a) Adrenaline 0.2cc sc, 2) Benadryl 25 mg IM, 3) Oxygen
Started experiencing Vertigo, I am still having symptoms.  Been to the doctor 3 times.  Seeing ENT this week
Fatigue, body pain, burning eyes, felt exhausted.  Hives & welts on thighs & arms started next day around noon. Had to go to Urgent Care this morning & was given Prednisone, Flamodine & Benadryl for night time.
Adequate vaccination with HIB, patient subsequently developed Haemphite infection of the url airway.
About 20 minutes after the vaccine my head started to feel dizzy, pressure headache and harder to think.  It felt like when I had IV before surgery like a medicine head and continued for 4 straight hours.  I continued to have a pressure headache and some dizziness for 3 straight days and now I continue to have on and off dizziness but no headache.
Flair up of Alopecia Areata following vaccination. Consistent hair loss since April 2021 continuing still today, September 2021
Patient was adm the Janssen Covid Vaccine authorized for 18+ year olds and the patient was under 18yo.  As of today, she did not have any adverse effects from this vaccination.
A doughnut sized red and puffy raised area occurred immediately after the H1N1 shot but subsided after 5 minutes.  Later that night became very ill with temp of 102.5, chills, aches, sweating and not feeling well.  Felt like the flu he says. Was ill all weekend.  Returned to MD 12/15/09.  Much better today (12/15/09) but still has joint pains and fatigue.  Able to eat today.
Within 15-minutes of vaccination, the patient reported dizziness, lightheadedness, and nausea. EMS evaluated patient on-site and administered 4mg Ondansetron PO. Patient was hypertensive (156/84) in transport to Emergency Department. Patient remained hypertensive in ED. Discharged from ED with diagnoses of dizziness, nausea, resolved, secondary to vaccination.
After I got the second dose I got a headache that never went away. I was a little dizzy one day and I took my blood pressure and it was very high. It has continued to be high with my lower number being 99 at the best and 111 at the highest. The higher number was over 160 the first time I noticed. It has been six months and I still have a headache almost every day. The headache is dull and it never goes away. I have not been able to get into a doctor yet.
Myalgia, Fever, Diarrhea, Runny nose, chest tightness Narrative:
After adminstaration of medication, patient had thightness in the throat. Paramedic came and took vitals signs and ekg.  Vitals are stable.  Patient symptoms subsided and he was release by the nurse.
Immunized 3/15/07 at 900am went to breakfast at 9. am at 1030 am began vomiting. resolved within 4 hours.
Information has been received from a nurse practitioner (NP), concerning a 37 year old female patient with drug hypersensitivity to BACITRACIN, NEOSPORIN who on 11-AUG-2006 at 2:15 pm was vaccinated with the first dose, 0.5ml, IM, of Gardasil (Lot #653650/0702F), and on 11-OCT-2006 at 5:39 pm with the second dose, 0.5ml, IM, of Gardasil (Lot #654540/0800F). Concomitant therapy included FLONASE and IBUPROFEN. The NP stated when the patient called to schedule her third dose of Gardasil, she reported that on 12-AUG-2006 following the first vaccination, she experienced dizziness and had "flu-like symptoms," including nausea, vomiting, diarrhea, arthralgia, myalgia, sleeplessness and fever (specified as "not above 100F"); she recovered on 17-AUG-2006. In addition, on 11-OCT-2006 following her second vaccination, the patient experienced identical events, and recovered on 16-OCT-2006. The NP stated she was "not sure that the patient should receive her third dose of the Gardasil." The patient sought unspecified medical attention. No further information is expected.
The days after the injection, 1 rash, approx. 2" x 6" appeared on lower bicep area of right arm. A few days later, this went away and than, a large, round liver-colored spot started on her right elbow (approximately 3" in circumf.). She came into store today, 8-25, to show me. It is neither hot, nor visibly swollen. She than proceeded to her PCP to show him.
Vaccine thawed >10 weeks and administered.  4-6 weeks  past 10 week thawed date.   Pt developed no signs or symptoms of anything
Patient reported: tender, sore, red below site of inject. No swelling. No rash.
About 12 hours after admin; arm, shoulder, neck pain, progressed to generalized body aches, nausea, severe headaches, cough, mass weakness,  diarrhea, joint pain. Symptoms started subsiding about 15 hours after onset. Minor cough still persist with minor shortness of breath.
Patient reports that she has experienced a decrease in range of motion and pain with her right should since receiving the Shingrix vaccine in the left shoulder.
THE PT FELT DIZZY & SAID HER HEART WAS RACING THEN SHE STARTED SHAKING.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 10-APR-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # K024976 exp date 09-JUN-2016 (dose and route not reported). The temperature and time of excursion was 0.55 degrees C for 584 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Patient received 2nd dose of COVID-19 Moderna Vaccine on 16Feb2021 and tested positive for COVID-19 on 24May2021 via nasal swab.
Extreme swelling at site, fever that evening 101.3 highest temp.  Fatigue.
Patient states he was fine during the day then that evening developed swollen itchy eyes. Patient's eyes feel a little better this morniing. Took Benadryl.
Information has been received from a physician concerning a 16 year old female who was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast). There was no illness reported at the time of vaccination. The mother of the patient said that the patient experienced loss of period (amenorrhea) after receiving the first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) and the patient sought unspecified medical attention. Subsequently, the patient's period came back (date not reported). The patient experienced amenorrhea after receiving the second dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) and it subsequently had been approximately 4 to 5 months and the patient still did not get period. The patient was not pregnant during these times. Additional information has been requested.
sep89 pt vax hepta B. pt ex fatigue. pt hosp. w/ pneumonia on 05feb90.
Awakened at night for 2 nights after immunizations with "blood curdling screams" but was consolable. Has had rash since 2 days after vaccines, fine maculopapular rash on trunk.
A report was received from a consumer on 21 October 2003 concerning a vaccinee of unknown demography who received 3ml of Fluvirin on 20 October 2003. On 20 October 2003 the vaccinee received 3ml of Fluvirin. The vaccinee denied experiencing any adverse symptoms at the time of the report. No follow-up. Permission not granted to contact physician.
About 3 days after shot a Small Bump / knot / swelling  Appeared; I Massaged & Repeatedly Moved arm wSlight Tingling Off & On ( like a DULL toothache;  Called a CovidHelp Line & They suggested IF Fever seek further attention  However I?ve had No Fever
tingling sensation in left cheek and lip; Lymph nodes under arm of injection are swelling/Lymph nodes under arm of injection are painfull; Swelling of left cheek; Swelling of face; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling of left cheek), PARAESTHESIA (tingling sensation in left cheek and lip), SWELLING FACE (Swelling of face) and LYMPHADENOPATHY (Lymph nodes under arm of injection are swelling/Lymph nodes under arm of injection are painfull) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE and HYDROXYCHLOROQUINE for an unknown indication.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced SWELLING FACE (Swelling of left cheek) and SWELLING FACE (Swelling of face). On 24-Mar-2021, the patient experienced PARAESTHESIA (tingling sensation in left cheek and lip) and LYMPHADENOPATHY (Lymph nodes under arm of injection are swelling/Lymph nodes under arm of injection are painfull). At the time of the report, SWELLING FACE (Swelling of left cheek), PARAESTHESIA (tingling sensation in left cheek and lip), SWELLING FACE (Swelling of face) and LYMPHADENOPATHY (Lymph nodes under arm of injection are swelling/Lymph nodes under arm of injection are painfull) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information included Benadryl 1 dose.
Golf ball type swelling in left armpit next day after shot. Next day spread to left lat and pectoral. Extreme swelling still not back to normal 2 months later.
Received COVID -19 vaccine at approx 1800.    1845 - Extreme itching to sit and effected left arm, pain up into the shoulder and neck area. 1900 - Tingling to bottom lip with no facial swelling.  Took 50 mg of Benadryl and tingling and itching resolved.  Developed site reaction, redness at injection site.  Extremely painful arm the next day 12/24/2020.  Occasional itching  12/25/2020 - Chills / Body Aches / low grade temp / severe nausea and loss of appetite  12/27/2020 - ER with severe abdominal pain / flank pain / nausea.  Dx UTI / Kidney infection.  Unlikely related to vaccine per PCP.  1/1/2020 - 1/5/2020 - swollen lymph nodes.  Continued to have random bouts of body aches and chills that seem to have resolved.  Random itching of injection site. General fatigue.  Have had previous reaction to flu shot, mainly 10+ years ago when shot was not preservative free.  Headache, dizziness, had a syncopal episode after.  Had not had an issue in recent years as a lot of them are preservative free now.    Associate reported in casual conversation to Pharmacy Director Jan 5, 2021
On September 16, 2022, I received the last of my 5 COVID-19 immunizations, namely the Pfizer Bivalent booster shot. On February 6, 2021, I have received my 1st COVID-19 vaccine. With the exceptions of the first two vaccines, I have had some of the typical reactions such as nausea and lethargy to some degree or another with the last reaction on 9/15/22 being the worse. Please note that I have taken many vaccines during my life including annual influenza vaccines, tetanus, pneumococcal vaccines of various kinds, and shingles vaccines.  I never had any adverse reactions to any extend close to the nausea and lethargy of the COVID vaccines, except the shingles vaccine that was a mild form of the reactions I have had with the COVID vaccines. However, this is not the reason that I am writing to  VAERS. I have been a type 1 insulin depended diabetic for almost 60 years. I take good care of myself and my average HA1C since 2000 has been 6.23. I want to report an adverse effect of the Pfizer mRNA COVID vaccine that was probably not detected during clinical trials. And that is the impact on insulin depended Type 1 diabetics. In most cases, I took the COVID vaccine during the afternoon hours, so the adverse reactions do not manifest until the following day. For 2 or 3 days after the vaccine, I have noticed extreme resistance to my insulin injections. As I indicated previously my type 1 diabetes has been well under control and that is not by accident. So, when I speak of resistance to the syringe/pen insulin injection resistance, I am speaking with confidence. Both long acting and short acting insulins seem cannot control my blood glucose (monitored by a CGM). I have to inject ridiculous amount of short acting insulin to just keep my glucose levels stable, let alone lower them to levels that I am accustom to. I repeat that this does not happen to me except the occasions after the COVID vaccine injections.  I think that given the numbers of people in my condition possibly affected by the COVID vaccine, the authorities and manufacturer(s) need to take a closer look at this issue. My main concern is that the COVID vaccine will become an annual event, just like the flu vaccine.
Temperature Excursion. Vaccine was stored refrigerated (2-8 degrees Celsius) for greater than 10 weeks.  Vaccine was stored for a total of 4  days past its beyond use date in the refrigerator.
had Shingles vaccinations and developed / full blown Shingles/suspected vaccination failure; Full blown shingles; Painful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.  It was unknown if the reporter considered the vaccination failure,shingles and pain to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had Shingles vaccinations and developed the most horrific painful case of full blown Shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory test confirming shingles were not provided.
This spontaneous report was received from a certified medical assistant, referring to multiple unspecified patients of unknown age and gender. Information about patients' medical history, concurrent conditions and concomitant medication were not reported. On unspecified dates, the patients were administered doses of improperly stored VAQTA (lot # M039202 expiration date: 11-MAR-2018) for prophylaxis. The vaccines were exposed to 32 degrees F to 35 degrees F (0 degrees C to 1 degrees C) and the cumulative time was 32 hours. A data logger was used. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA007407: US-009507513-1703USA007408: US-009507513-1703USA007409.
swelling, redness & warmth @ inj site in rt arm; this extended to shoulder area; pt c/o pain on movement; This lasted approx 10 days; mom consulted PMD by phone;